Your session is about to expire
← Back to Search
Automated text message reminder for Hearing Loss
N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after enrollment
Awards & highlights
Study Summary
This trial will test whether text message reminders encourage elderly patients to discuss hearing assessment with their primary care providers, in order to improve access to hearing healthcare.
Eligible Conditions
- Hearing Loss
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Likelihood of patient-physician discussion of hearing loss or hearing assessment
Secondary outcome measures
Hearing Tests
Likelihood of obtaining hearing aids
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Automated Text Message ReminderExperimental Treatment1 Intervention
Participants will receive automated reminder text instructing them to discuss hearing issues with their PCPs, and to request a referral to audiology or otolaryngology if they have hearing loss.
Group II: Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Automated text message reminder
2022
N/A
~50
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,009 Total Patients Enrolled
2 Trials studying Hearing Loss
653 Patients Enrolled for Hearing Loss
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You had hearing loss during your childhood.You wear a hearing aid.You have a cell phone with a valid phone number.You have difficulty understanding or communicating in English.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Automated Text Message Reminder
- Group 2: Control Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has the enrollment window for this trial opened, and if so, what are the criteria?
"Data hosted on clinicaltrials.gov verifies that this particular trial is not actively enrolling participants, with the initial posting date being October 17th 2022 and the last update occurring on said day as well. Although it appears to be inactive presently, there are 165 other trials currently recruiting volunteers."
Answered by AI
Who else is applying?
What state do they live in?
Nevada
California
How old are they?
18 - 65
What site did they apply to?
Stanford University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Share this study with friends
Copy Link
Messenger